The earnings call highlighted significant strategic moves, particularly the sale of the Passenger business to Joby Aviation, which positions the company for focused growth in the Medical division. The Medical division showed strong revenue growth and future potential, supported by strategic partnerships and cash reserves. However, challenges in the Passenger segment and increased maintenance costs slightly dampened the overall positive outlook.

Company Guidance -

Q3 2025

During the Blade Air Mobility Fiscal Second Quarter 2025 Earnings Release Conference Call, significant guidance was provided regarding the company's strategic transformation. Blade announced the sale of its Passenger business to Joby Aviation for up to $125 million, marking a pivotal shift to focus solely on its Medical division, which will be renamed Strata Critical Medical. This transition is expected to enhance value creation, as the Medical segment has grown from 12% of revenue in 2020 to approximately 60% in 2024, contributing to 85% of Blade's adjusted EBITDA. The Medical segment's revenue rose by 17.6% year-over-year to $45.1 million in Q2 2025, with adjusted EBITDA margins improving from 11.4% in Q1 to 13.4% in Q2. Blade expects the sale to be EBITDA and free cash flow neutral, with approximately $7 million in corporate cost efficiencies anticipated. The company aims for mid-teens revenue growth in the latter half of 2025, and has a robust $200 million cash position post-sale to support strategic acquisitions. Strata's leadership team, including Co-CEOs Melissa Tomkiel and Will Heyburn, will focus on executing a disciplined capital allocation strategy to drive organic and inorganic growth, with potential additional proceeds of up to $35 million contingent on employee retention and financial metrics.

Sale of Blade Passenger Business to Joby Aviation

Blade announced the sale of its Passenger business to Joby Aviation for up to $125 million. This transaction is aimed at unlocking the full potential of Blade's Medical division, which has grown to approximately 60% of revenue and 85% of segment's adjusted EBITDA.

Strong Performance of Medical Division

Medical revenue accelerated its growth to 18% in Q2 2025 versus the prior year period. Medical revenues rose 17.6% year-over-year to a record $45.1 million in Q2 2025. The Medical segment adjusted EBITDA margin increased to 13.4% in Q2 2025 from 11.4% in Q1 2025.

Positive Outlook and Strategic Partnership

Blade's Medical division is entering a long-term partnership with Joby Aviation to gain access to Joby's eVTOL aircraft for medical use. The company plans to focus on organic growth and strategic acquisitions supported by approximately $200 million of cash.

Improvement in Passenger Segment Profitability

Despite challenges, Passenger segment adjusted EBITDA tripled year-over-year from $0.8 million to $2.4 million. The Passenger segment flight margin rose 580 basis points year-over-year to 30.5% in Q2 2025.

Blade Air Mobility (BLDE) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

BLDE Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Nov 05, 2025	2025 (Q3)	0.01 / -	-0.03	―	―	―
Aug 05, 2025	2025 (Q2)	-0.04 / -0.05	-0.15	66.67% (+0.10)
May 12, 2025	2025 (Q1)	-0.12 / -0.04	-0.06	33.33% (+0.02)
Mar 13, 2025	2024 (Q4)	-0.12 / -0.13	-0.45	71.78% (+0.32)
Nov 12, 2024	2024 (Q3)	-0.02 / -0.03	0	―
Aug 07, 2024	2024 (Q2)	-0.03 / -0.15	-0.17	11.76% (+0.02)
May 07, 2024	2024 (Q1)	-0.10 / -0.06	-0.14	57.14% (+0.08)
Mar 12, 2024	2023 (Q4)	-0.12 / -0.45	-0.22	-104.55% (-0.23)
Nov 08, 2023	2023 (Q3)	-0.07 / 0.00	-0.129	―
Aug 09, 2023	2023 (Q2)	-0.13 / -0.17	0.1	-270.00% (-0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

BLDE Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 05, 2025	$4.43	$4.16	-6.09%
May 12, 2025	$2.92	$3.46	+18.49%
Mar 13, 2025	$2.83	$3.03	+7.07%
Nov 12, 2024	$3.83	$3.49	-8.88%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Blade Air Mobility, Inc. (BLDE) report earnings?

Blade Air Mobility, Inc. (BLDE) is schdueled to report earning on Nov 05, 2025, After Close (Confirmed).

What is Blade Air Mobility, Inc. (BLDE) earnings time?

Blade Air Mobility, Inc. (BLDE) earnings time is at Nov 05, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is BLDE EPS forecast?

BLDE EPS forecast for the fiscal quarter 2025 (Q3) is 0.01.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing